KATHLEEN WALLACE: Open Payments
NPI 1225035504 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 77 payments from 17 companies in 2025. Trend: 2023 $510 · 2024 $967 · 2025 $1,600
Food & beverage: $1,582Education: $18
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 14 | $295 |
| Novartis Pharmaceuticals Corporation | 11 | $243 |
| AstraZeneca Pharmaceuticals LP | 9 | $214 |
| Travere Therapeutics, Inc. | 10 | $208 |
| Amgen Inc. | 12 | $172 |
| Fresenius USA Marketing, Inc. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Genentech USA, Inc. | 1 | $30 |
Products named: IBSRELA, FARXIGA, KRYSTEXXA, VELPHORO, Vanrafia, Fabhalta, TAVNEOS, JYNARQUE.
Industry payments across IN — which companies pay providers there.
